Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Avrobio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AVRO
Nasdaq
8731
https://www.avrobio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Avrobio Inc
Avrobio’s road ends in reverse merger with Tim Springer-backed startup
- Jan 31st, 2024 11:42 am
AVROBIO and Tectonic Therapeutic Announce Merger
- Jan 30th, 2024 1:00 pm
Is AVROBIO (AVRO) Stock Outpacing Its Medical Peers This Year?
- Nov 8th, 2023 2:40 pm
Is AVROBIO (AVRO) Outperforming Other Medical Stocks This Year?
- Oct 23rd, 2023 1:40 pm
Has AVROBIO (AVRO) Outpaced Other Medical Stocks This Year?
- Oct 6th, 2023 1:40 pm
AVROBIO (AVRO) to Explore Strategic Options, Stock Rises 46%
- Jul 13th, 2023 11:08 am
AVROBIO to Explore Strategic Alternatives
- Jul 12th, 2023 11:00 am
AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million
- Jun 12th, 2023 11:00 am
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
- May 22nd, 2023 11:00 am
Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To 36 Months
- May 18th, 2023 6:53 pm
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis at the ASGCT 26th Annual Meeting
- May 18th, 2023 11:00 am
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update
- May 11th, 2023 11:00 am
Scroll